Silexion Therapeutics Corp
SLXN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002022416
No open-market purchases or sales by Silexion Therapeutics Corp insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $42.5K in total; no superinvestor holds it.
Other share classesSLXNW
Q4 2025 vs. Q3 2025
How the institutions holding Silexion Therapeutics Corp changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 4 | 6 | +2 |
| Shares | 5.08K | 18.3K | +13.2K (+260.2%) |
| Value | $17.3K | $35.2K | +$17.9K (+103.4%) |
New holders (2)
Institutions that held Silexion Therapeutics Corp at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 12,205 | $23.4K | 0.00% |
| Jones Financial Companies LLLP | 26 | $50 | 0.00% |
Sold out (0)
Institutions that held Silexion Therapeutics Corp at the end of Q3 2025 and filed for Q4 2025 without it.
None.